We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Proteostasis Therapeutics Inc | NASDAQ:PTI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.11 | 1.12 | 1.14 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
||
SCHEDULE 13G
|
||
Under the Securities Exchange Act of 1934
|
||
(Amendment No. 1)
*
|
Proteostasis Therapeutics, Inc.
|
||
(Name of Issuer)
|
Common Stock, par value $0.001 per share
|
||
(Title of Class of Securities)
|
74373B109
|
||
(CUSIP Number)
|
December 31, 2016
|
||
(Date of Event which Requires Filing of this Statement)
|
(a)
|
Name of Issuer
|
Proteostasis Therapeutics, Inc.
|
|
(b)
|
Address of Issuer’s Principal Executive Offices
|
200 Technology Square, 4th Floor
Cambridge, Massachusetts 02139
|
(a)
|
Name of Person Filing
|
Cormorant Global Healthcare Master Fund, LP
Cormorant Global Healthcare GP, LLC Cormorant Asset Management, LLC Bihua Chen |
|
(b)
|
Address of Principal Business Office or, if none, Residence
|
200 Clarendon Street, 52nd Floor
Boston, MA 02116
|
|
(c)
|
Citizenship
|
Cormorant Global Healthcare Master Fund, LP - Cayman Islands
Cormorant Global Healthcare GP, LLC - Delaware Cormorant Asset Management, LLC - Delaware Bihua Chen - United States |
|
(d)
|
Title of Class of Securities
|
Common Stock
|
|
(e)
|
CUSIP Number
|
74373B109
|
Item 3. |
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
(a)
|
[ ]
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
(b)
|
[ ]
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
(c)
|
[ ]
|
Insurance Company as defined in Section 3(a)(19) of the Act
|
(d)
|
[ ]
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
(e)
|
[ ]
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
(f)
|
[ ]
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
(g)
|
[ ]
|
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
(h)
|
[ ]
|
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
(i)
|
[ ]
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
(j)
|
[ ]
|
A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);
|
(k)
|
[ ]
|
Group, in accordance with §240.13d-1(b)(1)(ii)(K).
|
Item 4. |
Ownership***
|
(a)
|
Amount Beneficially Owned***
|
|
Cormorant Global Healthcare Master Fund, LP – 3,170,002 shares
Cormorant Global Healthcare GP, LLC - 3,170,002 shares Cormorant Asset Management, LLC - 3,804,027 shares Bihua Chen - 3,804,027 shares |
||
(b)
|
Percent of Class
|
|
Cormorant Global Healthcare Master Fund, LP – 12.7%
Cormorant Global Healthcare GP, LLC – 12.7% Cormorant Asset Management, LLC - 15.2% Bihua Chen - 15.2% |
||
(c)
|
Number of shares as to which such person has:
|
|
(i)
|
sole power to vote or to direct the vote
|
|
Cormorant Global Healthcare Master Fund, LP - 0 shares
Cormorant Global Healthcare GP, LLC - 0 shares
Cormorant Asset Management, LLC - 0 shares
Bihua Chen - 0 shares
|
||
(ii)
|
shared power to vote or to direct the vote
|
|
Cormorant Global Healthcare Master Fund, LP – 3,170,002 shares
Cormorant Global Healthcare GP, LLC - 3,170,002 shares Cormorant Asset Management, LLC - 3,804,027 shares Bihua Chen - 3,804,027 shares |
||
(iii)
|
sole power to dispose or to direct the disposition of
|
|
Cormorant Global Healthcare Master Fund, LP – 3,170,002 shares
Cormorant Global Healthcare GP, LLC - 3,170,002 shares Cormorant Asset Management, LLC - 3,804,027 shares Bihua Chen - 3,804,027 shares |
||
(iv)
|
shared power to dispose or to direct the disposition of
|
|
Cormorant Global Healthcare Master Fund, LP – 3,170,002 shares
Cormorant Global Healthcare GP, LLC – 3,170,002 shares Cormorant Asset Management, LLC - 3,804,027 shares Bihua Chen - 3,804,027 shares |
Item 8. |
Identification and Classification of Members of the Group
|
Item 9. |
Notice of Dissolution of Group
|
Item 10. |
Certification
|
1 Year Proteostasis Therapeutics Chart |
1 Month Proteostasis Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions